Lupin Ltd (LUPN.BO)
23 Jun 2017
* Says Lupin launches generic Topicort LP Emollient cream and Topicort cream in the U.S.
** Shares of Lupin Ltd fall as much as 2.3 pct to 1,070.1 rupees, their lowest since July 2014
* Says launches generic Wellbutrin XL tablets in the U.S. Source text: (http://bit.ly/2tpruCi) Further company coverage:
* Says Lupin receives FDA approval for generic Roxicodone tablets
** Lupin Ltd falls as much as 7.7 pct to its lowest since Aug. 8, 2014
MUMBAI Indian drugmaker Lupin Ltd expects to launch over 30 products in the United States this year, but warned revenue growth would remain muted due to growing pricing pressure and competition in the world's largest healthcare market.
* Q4 net profit 3.80 bln rupees vs est. 6.45 bln rupees (Adds comments from interview with managing director)
* MD Nilesh Gupta says expects to launch more than 30 products in US in FY18
MUMBAI, May 24 Lupin Ltd, India's second-largest drugmaker by sales, reported that its quarterly net profit nearly halved from a year ago, coming in well below analysts' expectations as sales slumped in its largest market the United States.
* Consensus forecast for March quarter consol profit was 6.45 billion rupees